F.D.A. Approves the First New Schizophrenia Drug in Decades
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
verywellhealth9d
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
FDA Approves Potentially Groundbreaking Schizophrenia Drug
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...
Why approval of KarXT, the first new drug for schizophrenia in decades, is a big deal
After more than three decades, schizophrenia patients have a new treatment option. The US FDA has approved a drug, known as ...
Bristol Myers wins US FDA approval for new type of schizophrenia drug
The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
The Washington Post on MSN13d
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
He was responsible for launching the company’s last major drug to treat schizophrenia, the antipsychotic Abilify, in 2002.
Chemistry World6d
US approves schizophrenia drug with new mode of action
The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...
Yahoo Finance13d
Bristol Myers schizophrenia drug, the first of its kind, approved by FDA
Recommended Reading Psychiatry drugs finally have ... than a dozen antipsychotics for schizophrenia, and many have ...
US FDA approves Bristol Myers' schizophrenia drug
Bristol Myers obtained the drug Cobenfy, also known as KarXT, through its $14 billion takeover of Karuna Therapeutics last ...
US FDA approves Bristol Myers' Squibb drug for treating schizophrenia
Bristol Myers obtained the drug Cobenfy, also known as KarXT, through its $14 billion takeover of Karuna Therapeutics last ...